Cortactin expression assessment improves patient selection for a watchful waiting strategy in pT1cN0-staged oral squamous cell carcinomas with a tumor infiltration depth below 4 mm.

Cortactin expression assessment improves patient selection for a watchful waiting strategy in pT1cN0-staged oral squamous cell carcinomas with a tumor infiltration depth below 4 mm.
复制标题

Corpine表达评估可改善肿瘤浸润深度低于4 mm的pT1cN0期口腔鳞状细胞癌患者的观察等待策略选择

DOI:
10.1002/hed.26746
复制
发表时间:
2021-09
期刊:
Head & neck
影响因子:
--
通讯作者:
Schuuring E
Schuuring E
中科院分区:
其他
文献类型:
--
作者:
Boeve K;Mastik MF;Slagter-Menkema L;van Dijk BAC;Roodenburg JLN;van der Laan BFAM;Witjes MJH;van der Vegt B;Schuuring E

文献摘要

参考文献

被引文献

相似文献

在这项可行性研究中,我们的目的是评估先前报道的与口腔鳞状细胞癌(OSCC)淋巴结转移相关的分子肿瘤生物标志物的价值,以优化颈部策略选择标准。在一系列87例(cT 1 - 2N 0)接受原发性切除和SLNB手术治疗的OSCC患者中,评价了corneum、cyclin D1、FADD、RAB 25和S100 A9表达与前哨淋巴结状态之间的相关性。肿瘤浸润深度和肿瘤浸润模式是SLN状态的独立预后标志物,而在整个队列中,没有一个肿瘤标志物显示出更好的预后价值,以取代SLNB作为颈部分期技术。然而,在pT 1 N 0 OSCC患者亚组中,corneum表达(OR 16.0,95%CI 2.0-127.9)与SLN分类相关。coronin的表达是一种有前途的免疫组织化学肿瘤标记物,用于识别可能无法从SLNB或END中获益的低风险患者。
In this feasibility study we aimed to evaluate the value of previously reported molecular tumor biomarkers associated with lymph node metastasis in oral squamous cell carcinoma (OSCC) to optimize neck strategy selection criteria. The association between expression of cortactin, cyclin D1, FADD, RAB25, and S100A9 and sentinel lymph node status was evaluated in a series of 87 (cT1‐2N0) patients with OSCC treated with primary resection and SLNB procedure. Tumor infiltration depth and tumor pattern of invasion were independent prognostic markers for SLN status, while none of the tumor makers showed a better prognostic value to replace SLNB as neck staging technique in the total cohort. However, in the subgroup of patients with pT1N0 OSCC, cortactin expression (OR 16.0, 95%CI 2.0–127.9) was associated with SLN classification. Expression of cortactin is a promising immunohistochemical tumor marker to identify patients at low risk that may not benefit from SLNB or END.
DOI: 10.1002/lary.27323
发表时间: 2019-01-01
期刊: LARYNGOSCOPE
影响因子: 2.6
作者:
Cramer, John D.;Sridharan, Shaum;Samant, Sandeep
通讯作者: Samant, Sandeep
DOI: 10.1158/1078-0432.ccr-07-1247
发表时间: 2007-11-01
影响因子: 11.5
作者:
Gibcus, Johan H.;Menkema, Lorian;Schuuring, Ed
通讯作者: Schuuring, Ed
哨兵淋巴结活检在早期口服鳞状细胞癌中的诊断功效:66项研究的荟萃分析。
DOI: 10.1371/journal.pone.0170322
发表时间: 2017
期刊: PloS one
影响因子: 3.7
作者:
Liu M;Wang SJ;Yang X;Peng H
通讯作者: Peng H
DOI: 10.1245/s10434-009-0755-3
发表时间: 2010-02-01
影响因子: 3.7
作者:
Goerkem, Mete;Braun, Julia;Stoeckli, Sandro J.
通讯作者: Stoeckli, Sandro J.
DOI: 10.1016/j.oraloncology.2013.07.008
发表时间: 2013-10-01
期刊: ORAL ONCOLOGY
影响因子: 4.8
作者:
Melchers, L. J.;de Bruin, L. Bruine;Schuuring, E.
通讯作者: Schuuring, E.